PATENT CLAIM ANALYSIS

Application Number: 15907239
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "326000"]

Abstract:
The invention provides a drug combination of at least two compounds selected from the group consisting of Valproate, Ketamine, Tacrolimus, Clevidipine and Joro Spider Toxin that can be administered parenterally or orally to patients over 18 years of age at the onset of stroke symptoms or Transient Ischemic Attack (TIA). The drug combination may be administered regardless of stroke etiology (ischemic vs. hemorrhagic); may be given up to 6 hours following the onset of stroke and should not interfere with the subsequent action of thrombolytic agents such as tPA (Tissue Plasminogen Activator).

Claim (Index 13):
A pharmaceutical composition for the treatment of a brain ischemic or hypoxic injury comprising a mixture of effective amounts of at least 2 compounds selected from the group consisting of Valproate, Ketamine, Tacrolimus, Clevidipine, Nicardipine and Joro Spider Toxin, or their pharmaceutically acceptable salts, enantiomers, racemates, prodrugs, derivatives or metabolites. and one or several pharmaceutically acceptable excipient(s) or carrier(s).

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.40541
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14002429', '14911943', '11359946', '12086605', '14426832']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7377251640646523
- 35 USC 102 Novelty (BERT): 0.5457377725120423
- Combined Prediction Score: 0.7185264249093913
- Mean Citation Score: 300.2679280000001
- Max Citation Score: 417.15814
- Similarity Product: 272.54305821577066

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test